Stocks and Investing Stocks and Investing
Thu, March 16, 2023
Wed, March 15, 2023
Tue, March 14, 2023
Mon, March 13, 2023

Oren Livnat Maintained (ANIP) at Strong Buy with Increased Target to $53 on, Mar 13th, 2023


Published on 2024-10-28 02:14:45 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $50 to $53 on, Mar 13th, 2023.

Oren has made no other calls on ANIP in the last 4 months.



There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $55 on, Wednesday, March 1st, 2023